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A B S T R A C T
Background: The presence of an infected family member significantly increases the risk of HBV transmission, but many socio-demographic 
and viral characteristics of family members affect the transmission rate.
Objectives: In this study, we have used data mining techniques to investigate the impact of different variables in intrafamilial transmission 
of HBV infection.
Patients and Methods: demographic information, viral markers, and medical history of 330 patients with chronic hepatitis B and their 
offspring attending a referral center in Tehran were collected. Data-mining techniques were administered to detect patterns.
Results: The overall transmission rate was 15.7% (5.4% and 27.3% for male and female index cases respectively). In female patients, HBe Ag 
positively affected the transmission rate (49% vs. 23.4%). There was a dominant change in transmission rate of female patients with negative 
results for Hbe Ag with HDV coinfection, where the transmission rate changed from 25% in patients with negative results for HDV Ab to 5% 
in those with positive results. In Hbe Ag negative male index cases, the transmission rate was 1.3% in cases with positive results for HDV Ab 
compared to 7% in those with negative findings. The overall transmission rate was statistically different between patients with positive and 
negative results for HDV Ab (P = 0.016).
Conclusions: There is a minor but consistent pattern change in the presence of HDV infection which reduces familial transmission of HBV, 
especially in female patients with negative results for HBe Ag.
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a better understanding of the pathogenesis of the disease and suggest new protective methods
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1. Background
The prevalence of Hepatitis B virus (HBV) infection var-
ies among the countries around the world (1). Chronic 
hepatitis B infection affects less than 0.5% to more than 
10% of people in different parts of the world, and it is es-
timated that more than 350 million people are infected 
worldwide (2). It is a major public health issue and has 
a high burden on health systems (3). Apart from acute 
manifestations, the infection imposes high burden on 
health systems especially due to its sequels; cancer and 
cirrhosis. One of the determining factors associated with 
high burden of hepatitis B is the relative high transmis-
sion rate of the infection. The intrafamilial transmission 
of the infection is an important concern for patients and 
their family as well as health service providers and policy 
makers. Many strategies such as neonatal vaccination 
and hepatitis B immunoglobulin (HBIG) injection to the 
newborns of infected mothers have been proposed and 
administered (4). The disease can be transmitted both 
vertically (from infected mothers to offspring) and hori-
zontally (between the spouses or children) in the family 
(5). Both perinatal transmission from mother to child and 
horizontal transmission from parents and other sibling 
during childhood are important (6).It is estimated that 
about 90% of vertically infected infants would progress to 
chronic hepatitis. About 30% to 50% of the infected chil-
dren between the first and 5th year will become chroni-
cally infected while the rate is as low as 5% in adults (7). Ac-
quiring the disease in younger age increases the chance 
of developing chronic disease significantly, which high-
lights the importance of protective measures against 
newborn infection (2). Many studies have shown that the 
presence of an infected family member significantly in-
creases the risk of HBV transmission (5, 8) while the risk 
of transmission varies based on socio-demographic vari-
ables, family role (mothers infection increases the risk of 
transmission) and viral markers of the index case (5, 6, 
9) .Iran has low to intermediate HBV prevalence (3) .The 
prevalence has declined in recent years probably due to 
national vaccination programs (3).
Vaccination against HBV has changed the global picture 
of HBV infection, but still a considerable number of peo-
ple become infected annually. The coverage of vaccine is 
not complete, and many high risk populations are not 
vaccinated (2) .Even in vaccinated populations, the long 
term protective effect of the HBV vaccine is not clear, and 
immunity may diminish after a few decades or when im-
mune system is weakened due to other health conditions 
(10) or when some of the HBV subtypes are present (11). 
Discovering hidden patterns in transmission of Hepatitis 
B virus can be a start point in developing techniques to 
reduce transmission of the infection. The development of 
information systems and medical databases has provid-
ed the opportunity to use machine learning techniques 
to detect the associations and patterns between numer-
ous variables in medical fields. These methods are effec-
tive in investigating medical field data with high level 
of uncertainty, missing and inaccuracy (12). Data mining 
techniques can extract unknown and useful information 
and pattern about the data. Policy makers and healthcare 
providers can benefit from the extracted patterns, to im-
prove the quality of care, reduce the costs, and forecast 
the need for resources and prognosis of the patients (13). 
In some cases the extracted patterns can be applied even 
without full comprehension of the casual mechanisms 
(14). Investigating the transmission patterns in infectious 
disease can result in discovering new patterns and identi-
fying methods to reduce transmission and better allocat-
ing resources (15).
2. Objectives
In this cross-sectional study, we aimed to investigate the 
intrafamilial transmission patterns in families with HBV 
infection and explore the variables which could change 
the patterns and transmission rates between the sub-
groups.
3. Patients and Methods
In this cross-sectional study, demographic information, 
viral markers, stage of disease (inactive carriers, chronic 
hepatitis and liver cirrhosis), and family history of liver 
disease of all cases with chronic B hepatitis referred to 
Middle East Liver Disease (MELD) center were gathered 
between 2009 and 2011. This is a referral center in the city 
of Tehran which admits referred patients from other clin-
ics in the city as well as all over the country. The index case 
was the first parent in the family who was identified as 
HBV infected. Demographic information and viral mark-
ers of their offspring were also collected. The participants 
were cases with chronic HBV infection (more than six 
months with positive findings for HBs Ag). Patients with 
HIV, HCV, acute hepatitis B infection, and patients never 
married, younger than 18 years old, and those who did 
not provide their written consent were excluded from 
the study. All data were recorded by one physician in a 
check list based on medical records, physical examina-
tion, and past medical history of the patient and his or 
her offspring. The final diagnosis was made by a special-
ist. All patients provided their written informed consent 
before the data collection. The data were analyzed using 
network analysis method where each case was evaluated 
in respect to all other cases. This method is applied to 
explore the structural and relational aspects of various 
health issues such as disease transmission (e.g. HIV/AIDS 
and other sexually transmitted diseases), information 
transmission, and health aspects of social networking 
(16). We used feature selection analysis to choose the ef-
fective factors and include them in the model. Feature 
selection which is also called variable selection or feature 
reduction has been used to select the most relevant vari-
ables, and to help removing irrelevant and redundant 
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ones from learning process of modeling. This phase has a 
paramount importance for the next step which is extract-
ing best and most reliable patterns from data. The im-
portance of this step is due to the fact that entering poor 
set of features (incomplete, noisy, irrelevant and redun-
dant) may result in difficulties in finding patterns. It may 
even end in identifying poor and misleading patterns. 
At the other hand feature selection helps to identify the 
most and least relevant fields for analysis. Feature selec-
tion can be used for two aims: first for feature ranking 
and extracting most important features, and second for 
subset selection to search for the set of features that can 
be included in the optimal subset. In this study we used 
feature selection for feature ranking and no subset selec-
tion was performed. There are several methodological 
approaches available for feature selection, and we used 
Brute force method which selects the most important at-
tributes by trying all possible combinations of attributes 
in data set. RapidMiner version 5 was used to perform 
the analysis. We used CHAID (Chi-squared Automatic In-
teraction Detection) algorithm for modeling, which is a 
decision tree representation model, based upon adjusted 
significance testing of Bonferroni. CHAID algorithm eval-
uates the associations between variables by exploratory 
analysis methods, and is an enhanced alternative to mul-
tiple linear regression and logistic regression. The origi-
nal CHAID algorithm was introduced by Kass for nominal 
dependent variables, and extended to ordinal dependent 
variables by Magidson (17). CHAID output is highly visual 
and easy to understand like other decision tree repre-
senting algorithms. The main advantage of CHAID is its 
ability to build nonbinary tree (trees with more than 
two branches attached to a node). Statistical analysis was 
performed using SPSS version 16. Data were presented as 
mean and standard deviation, and Chi square and fisher 
exact test were used for analysis of categorical data.
4. Results
A total of 390 patients, 176 (45%) females and 214 (55%) 
male participated in this study. Mean age of the partici-
pants was 47 years (SD: 11.7), and they were between 18 
and 71 years old. Patients were referred to clinic follow-
ing screening or routine check-up (33%), positive findings 
during blood donation (27%), clinical symptoms (21%), 
and having a case with positive results in their family 
(19%). Fifty one patients had positive results for HBe-Ag, 
and 41 patients had positive findings for HDV-Ab. The 
participants had 909 offspring (43% female), from whom 
the viral markers of 740 (48% female) were available. The 
age range of the offspring was between 1 and 45, and the 
mean age was 17 (SD: 9.9). The final model can be observed 
in Figure 1. Gender, age of children, HBe Ag and HDV Ab 
were present in the model. The overall transmission rate 
was 15.7% (95% confidence interval was 13% – 18.5%). Gen-
der of the index case was the first effective variable. The 
most important finding in this model was the difference 
in transmission pattern for male and female patients 
(Figure 1). The transmission rate was 5.4% when index 
case was male, and 27.3% when index case was female (P 
< 0.001). In female patients, HBe Ag had a determining 
effect on transmission rate (49% in mothers with positive 
results for HBe Ag compared to 23.4% in mothers with 
negative results for HBe Ag, P < 0.001). There was a domi-
nant change in transmission rate of female patients with 
negative results for HBe Ag with HDV coinfection, where 
the transmission rate changed from 25% in patients with 
negative results for HDV Ab to 5% in those with positive re-
sults. There was only one female index case with both HBe 
Ag and HDV Ab positive results, and the transmission rate 
was as high as 49%. In male patients, age of children was 
associated with different transmission rates (higher rate 
in older children). Male index cases had no infected child 
younger than 15 years old. HDV coinfection also had a 
similar effect on transmission pattern of male index cas-
es, and it reduced the transmission rate from 19.5% to 10% 
in children older than 23and from 6% to 0% in children 
between 15 and 23 years old. There was no male index case 
with positive results for HBe Ag and HDV Ab. For HBe Ag 
negative male index cases, the transmission rate was 1.3% 
in cases with positive results for HDV Ab compared to 7% 
in those with negative findings (P = 0.01). The transmis-
sion rate was 2.4% (95% confidence interval was 1%-12.8%) 
for HDV Ab positive index cases, and 16.4% (13.7%-19.4%) for 
HDV Ab negative index cases. The prevalence was signifi-
cantly different (P = 0.013).
Total cases
(%15.7)
Female index
case (%27.3)
Male index
case (%5.4)
Child age <=
15 y (%0)
Child age 15-
23 y (%5.6)
Child age > 23
 y (%14)
HBe Ag +
  (%49)
HBe Ag +
  (%23.4)
HDV Ab +
  (%0)
HDV Ab -
  (%6)
HDV Ab +
(%10)
HDV Ab -
(%19.5)
HDV Ab +
(%5)
HDV Ab -
(%25)
Figure 1. The Transmission Rate (%) of Patients in Different Subgroups of 
Patients, the Variables and Their Sequence Are Derived from the Model
5. Discussion
In this study we have proposed a decision tree for famil-
ial transmission of Hepatitis B which can help explore the 
disease transmission in patients’ offspring. The difference 
in decision tree in men and women is a primary finding 
of this study, which is observed in the previous studies 
(5, 6, 18). The difference is not observed in some studies, 
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although the transmission rate was higher when both 
parents were involved (8). The higher maternal transmis-
sion rate might be due to perinatal transmission of HBV, 
which can be reduced through preventive measures. Re-
searches have shown that the introduction of HBV vacci-
nation has resulted in lower intrafamilial transmission 
of HBV (19). Researchers have suggested screening preg-
nant women for HBV infection to reduce perinatal trans-
mission (20). The transmission may be present even after 
vaccination, especially in neonates of mothers with posi-
tive results for HBeAg. HBIG injection is also proposed to 
reduce perinatal transmission of the infection; although, 
it cannot fully protect the neonate (21). In male patients, 
age of children is an important variable which can be 
considered as a proxy of duration of exposure. No case of 
transmission was observed in children younger than 15 
years. In Iran, national vaccination of newborns against 
HBV started since 1993 which might have resulted in the 
reduced paternal transmission in this age category. In fe-
male patients who have higher transmission rate, it is the 
presence of HBeAg which determines transmission rate, 
similar to findings of Salkic et al. (22) but not confirmed 
in some other studies (23, 24). Age of the offspring did not 
change the transmission rate in contrast to male index 
cases. In our study, HDV infection decreased the trans-
mission rate of HBV between family members. There is 
a consistent pattern change in the presence of HDV in-
fection which reduces familial transmission, especially 
in patients with negative findings for Hbe Ag. Introduc-
tion of safe and effective HBV vaccines and integration of 
HBV vaccination in national immunization programs of 
many countries have resulted in decreased Hepatitis B in-
fection, which in turn reduced HDV infection despite its 
high infectivity (25, 26). Xiridou et al. have introduced a 
mathematical model which shows that hepatitis D infec-
tion modulates both the severity of the HBV epidemic and 
the impact of interventions for HBV (27). The frequency of 
HDV-HBV coinfection should be taken into account when 
investigating such effects. The aforementioned rate is 
7.8% in Iran which is lower than endemic countries (28). 
It is possible that the coinfection of HBV and HDV may 
reduce the viral load or weaken transmission by some 
other mechanism. This is a cross-sectional study and its 
ability to explore the causal associations is limited. The 
applied data mining methods is aimed to detect patterns 
and associations. Further studies are required to confirm 
these exploratory findings, and evaluate the consistency 
of these findings in different populations. If confirmed, 
effort can be made to place these patterns in hepatitis B 
transmission predicting models. Although vaccination is 
an effective protective method for hepatitis B infection, 
the induced immunity may diminish through decades 
(11). Other protective methods should be discovered and 
introduced to improve global efforts and reduce burden 
of the disease. The observed protective effect of HDV in-
fection can be a sign of an underlying mechanism. Other 
investigations in this field may result in a better under-
standing of the pathogenesis of the disease which in turn 
may lead to introduce new protective methods.
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